TY  - GEN
AU  - Mazagatos, Clara
AU  - Mendioroz, Jacobo
AU  - Rumayor-Zarzuelo, Mercedes Belén
AU  - Gallardo García, Virtudes
AU  - Álvarez Río, Virginia
AU  - Cebollada Gracia, Ana Delia
AU  - Batalla Rebollo, Noa
AU  - Barranco Boada, María Isabel
AU  - Pérez-Martínez, Olaia
AU  - Lameiras Azevedo, Ana Sofía
AU  - López González-Coviella, Nieves
AU  - Castrillejo, Daniel
AU  - Fernández Ibáñez, Ana
AU  - Giménez Duran, Jaume
AU  - Ramírez Córcoles, Cristina
AU  - Ramos Marín, Violeta
AU  - Larrauri, Amparo
AU  - Monge Corella, Susana
AU  - SARI Sentinel Surveillance RSV Study Group
PY  - 2024
DO  - 10.1111/irv.13294
UR  - http://hdl.handle.net/20.500.12105/19872
AB  - Background: Data from the sentinel surveillance system of severe acute respiratory infections in Spain were used to estimate the impact of administration of nirsevimab to children born from 1 April 2023 onwards. Methods: Estimated RSV hospitalisations...
LA  - eng
PB  - Wiley
KW  - SARI
KW  - Burden
KW  - Impact
KW  - Respiratory infections
KW  - Respiratory syncitial virus
KW  - Surveillance
KW  - Respiratory Syncytial Virus Infections
KW  - Hospitalization
KW  - Antiviral Agents
KW  - Humans
KW  - Spain
KW  - Infant
KW  - Incidence
KW  - Female
KW  - Male
KW  - Respiratory Syncytial Virus, Human
KW  - Sentinel Surveillance
KW  - Infant, Newborn
KW  - Antibodies, Monoclonal, Humanized
TI  - Estimated Impact of Nirsevimab on the Incidence of Respiratory Syncytial Virus Infections Requiring Hospital Admission in Children < 1 Year, Weeks 40, 2023, to 8, 2024, Spain
TY  - research article
ER  -